SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-254453
Filing Date
2018-08-22
Accepted
2018-08-22 07:15:35
Documents
5
Period of Report
2018-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d612613d8k.htm 8-K 29283
2 EX-99.1 d612613dex991.htm EX-99.1 15336
3 EX-99.2 d612613dex992.htm EX-99.2 8872
4 GRAPHIC g612613g34d91.jpg GRAPHIC 6418
5 GRAPHIC g612613logo.jpg GRAPHIC 3296
  Complete submission text file 0001193125-18-254453.txt   68575
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37490 | Film No.: 181031411
SIC: 2834 Pharmaceutical Preparations